Literature DB >> 10720620

Brain-derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain.

W C Covey1, T A Ignatowski, P R Knight, R N Spengler.   

Abstract

The pleiotropic cytokine tumor necrosis factor-alpha (TNFalpha) is implicated in the development of persistent pain through its actions in the periphery and in the central nervous system (CNS). Activation of the alpha(2)-adrenergic receptor is associated with modulation of pain, possibly through its autoregulatory effect on norepinephrine (NE) release in the CNS. The present study employs a chronic constriction nerve injury (CCI) pain model to demonstrate the interactive role of presynaptic sensitivity to TNFalpha and the alpha(2)-adrenergic autoreceptor in the pathogenesis of neuropathic pain. Accumulation of TNFalpha is increased initially in a region of the brain containing the locus coeruleus (LC) at day 4 post-ligature placement, followed by an increase in TNFalpha in the hippocampus at day 8 post-ligature placement, coincident with hyperalgesia. Levels of TNFalpha in the thoraco-lumbar spinal cord are also increased at day 8 post-ligature placement. Concurrently, alpha(2)-adrenergic receptor and TNFalpha-induced inhibition of NE release are increased, and stimulated NE release is decreased in superfused hippocampal slices isolated at day 8 post-ligature placement. Stimulated NE release is also decreased in spinal cord slices (lumbar region) from animals undergoing CCI, although in contrast to that which occurs in the hippocampus, alpha(2)-adrenergic receptor inhibition of NE release is not changed. These results indicate an important role that TNFalpha plays in adrenergic neuroplastic changes in a region of the brain that, among its many functions, appears to be a crucial link in the conscious perception of pain. We predict that neuroplastic changes, involving increased functional responses of alpha(2)-adrenergic autoreceptors and increased presynaptic sensitivity to TNFalpha, culminate in decreased NE release in the CNS. These neuroplastic changes provide a mechanism for the role of CNS-derived TNFalpha in the pathogenesis of persistent pain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720620     DOI: 10.1016/s0006-8993(00)01965-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

1.  Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain.

Authors:  S Ohnami; A Kato; K Ogawa; S Shinohara; H Ono; M Tanabe
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 3.  [Mirror therapy for inflammatory rheumatic pain: Potentials and limitations].

Authors:  R Bekrater-Bodmann
Journal:  Z Rheumatol       Date:  2015-11       Impact factor: 1.372

4.  Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines.

Authors:  E D Milligan; K A O'Connor; K T Nguyen; C B Armstrong; C Twining; R P Gaykema; A Holguin; D Martin; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

5.  Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release.

Authors:  Robert N Spengler; Reeteka Sud; Paul R Knight; Tracey A Ignatowski
Journal:  Neuropharmacology       Date:  2006-10-18       Impact factor: 5.250

6.  ISSLS PRIZE IN CLINICAL SCIENCE 2018: longitudinal analysis of inflammatory, psychological, and sleep-related factors following an acute low back pain episode-the good, the bad, and the ugly.

Authors:  David M Klyne; Mary F Barbe; Wolbert van den Hoorn; Paul W Hodges
Journal:  Eur Spine J       Date:  2018-02-19       Impact factor: 3.134

Review 7.  Looking beyond the intervertebral disc: the need for behavioral assays in models of discogenic pain.

Authors:  Grace E Mosley; Thomas W Evashwick-Rogler; Alon Lai; James C Iatridis
Journal:  Ann N Y Acad Sci       Date:  2017-08-10       Impact factor: 5.691

Review 8.  TNF-alpha and neuropathic pain--a review.

Authors:  Lawrence Leung; Catherine M Cahill
Journal:  J Neuroinflammation       Date:  2010-04-16       Impact factor: 8.322

9.  Antinociception occurs with a reversal in alpha 2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatory.

Authors:  Reeteka Sud; Robert N Spengler; Nader D Nader; Tracey A Ignatowski
Journal:  Eur J Pharmacol       Date:  2008-04-24       Impact factor: 4.432

10.  Spinal and supraspinal changes in tumor necrosis factor-alpha expression following excitotoxic spinal cord injury.

Authors:  Kori L Brewer; Todd A Nolan
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.